226950.KQ
OliX Pharmaceuticals,Inc
KOE · Healthcare · Biotechnology · KR
KRW 91,800.00
−8.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.83x
- Price / sales
- 135.92x
- Price / cash flow
- -61.61x
Enterprise value
- Enterprise value
- KRW 1.66T
- EV / sales
- 121.87x
- EV / EBITDA
- -42.37x
- EV / EBIT
- -39.99x
- Market cap
- KRW 1.85T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026